The estimated Net Worth of J Brent Alldredge is at least 1.88 百万$ dollars as of 29 July 2021. Mr Alldredge owns over 3,749 units of Conformis stock worth over 1,369,151$ and over the last 5 years he sold CFMS stock worth over 37,266$. In addition, he makes 470,497$ as Corp. Sec. at Conformis.
Mr has made over 4 trades of the Conformis stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 3,749 units of CFMS stock worth 5,511$ on 29 July 2021.
The largest trade he's ever made was selling 33,051 units of Conformis stock on 14 May 2021 worth over 25,119$. On average, Mr trades about 5,540 units every 46 days since 2019. As of 29 July 2021 he still owns at least 605,819 units of Conformis stock.
You can see the complete history of Mr Alldredge stock trades at the bottom of the page.
J. Brent Alldredge J.D. is the Corp. Sec. at Conformis.
As the Corp. Sec. of Conformis, the total compensation of Mr D at Conformis is 470,497$. There are 3 executives at Conformis getting paid more, with Mark Augusti having the highest compensation of 2,853,750$.
Mr D is 45, he's been the Corp. Sec. of Conformis since . There are 12 older and 1 younger executives at Conformis. The oldest executive at Conformis Inc. is Kenneth Fallon, 80, who is the Independent Chairman of the Board.
J's mailing address filed with the SEC is C/O CONFORMIS INC, 600 TECHNOLOGY PARK DRIVE, BILLERICA, MA, 01821.
Over the last 9 years, insiders at Conformis have traded over 10,769,806$ worth of Conformis stock and bought 583,200 units worth 267,840$ . The most active insiders traders include Capital Management Llcchris...、Philipp Lang、Mark A Augusti. On average, Conformis executives and independent directors trade stock every 21 days with the average trade being worth of 122,083$. The most recent stock trade was executed by Mark A Augusti on 7 May 2022, trading 22,396 units of CFMS stock currently worth 10,302$.
our mission patients vary in more ways than gender, race, and size. at conformis, we believe that optimizing implant fit and performance requires a patient-specific approach. our mission is to provide best-in-class, patient-specific implants and instrumentation that offer unique advantages over traditional orthopedic implants. we start with a simple idea: make the implant fit the patient rather than forcing the patient to fit the implant. our implants are individually sized and shaped to fit to each patient’s unique anatomy, providing precise anatomic fit and preserving healthy tissue. our disposable, patient-specific cutting and placement guides also eliminate many of the tools required for traditional orthopedic surgery and simplify surgical technique. by combining our personalized implants with our unique instrumentation, a surgeon is able to provide a custom solution that preserves more of a patient’s joint and minimizes surgical trauma. our company conformis, inc. is a privately h
Conformis executives and other stock owners filed with the SEC include: